CPMC Holdings Ltd represents a strong commitment to its core values and corporate philosophy. The company is dedicated to delivering exceptional quality and innovative solutions in the healthcare industry. CPMC Holdings Ltd prioritizes integrity and transparency in all its operations, ensuring trustworthy partnerships and investor confidence. With a customer-centric approach, the company strives to meet the diverse healthcare needs of its clients, fostering long-term relationships built on trust and reliability. CPMC Holdings Ltd aims to drive growth and create value for its stakeholders by embracing continuous improvement and embracing a culture of innovation.

CPMC Holdings Ltd is primarily present in China.

CPMC Holdings Ltd has achieved significant milestones in its trajectory. The company has successfully expanded its market presence, diversifying its product portfolio and maintaining steady growth. CPMC Holdings Ltd has demonstrated strong financial performance, delivering consistent revenue and profit growth year after year. The organization has also made notable strides in research and development, constantly innovating and enhancing its offerings. Through strategic partnerships and acquisitions, CPMC Holdings Ltd has strengthened its market position and gained a competitive edge. These achievements have further solidified CPMC Holdings Ltd's reputation as a leader in the industry, attracting investors and fueling its continued success.

CPMC Holdings Ltd is a leading company in the field of integrated packaging solutions. Established in (year), CPMC has a rich history and a strong background in providing high-quality packaging products and services in various industries. With a global presence and a customer-centric approach, CPMC prides itself on delivering innovative and customized solutions to meet client needs. Its extensive range of products includes (mention specific products). Over the years, CPMC has cemented its position as a trusted partner for businesses worldwide, thanks to its commitment to excellence, sustainability, and customer satisfaction.

The main competitors of CPMC Holdings Ltd in the market include company ABC, company XYZ, and company DEF. These companies operate in a similar industry and offer comparable products and services, competing with CPMC Holdings Ltd for market share and customer attention. CPMC Holdings Ltd differentiates itself from its competitors through its unique product features, customer service, and market positioning. As a leading stock website, we closely monitor market dynamics and track the performance of CPMC Holdings Ltd and its competitors to provide investors with comprehensive and up-to-date information for informed investment decisions.

CPMC Holdings Ltd is primarily active in the industries of packaging materials, paper and pulp, and tissue paper production.

The business model of CPMC Holdings Ltd focuses on the packaging industry. As a leading manufacturer and supplier, CPMC specializes in providing innovative packaging solutions for a wide range of industries such as food and beverage, healthcare, personal care, and industrial products. With a strong emphasis on research and development, CPMC offers customized packaging solutions to meet the specific needs of its customers. By leveraging its expertise in design, manufacturing, and distribution, CPMC aims to deliver high-quality, sustainable packaging solutions that maximize customer satisfaction and promote brand differentiation. CPMC Holdings Ltd is committed to driving growth, maintaining customer relationships, and staying at the forefront of the packaging industry.

Коефициентът на цена спрямо печалбата (КЦП) на CPMC Holdings е 10,61.

Коефициентът на цена към оборот (KUV) на CPMC Holdings е 0,55.

AlleAktien качественият резултат за CPMC Holdings е 7/10.

очаквана CPMC Holdings оборотът е 12,95 млрд. CNY.

очаквана CPMC Holdings печалба е 674,73 млн. CNY.

CPMC Holdings Ltd is a leading Chinese provider of pharmaceutical products, medical devices, and healthcare solutions for the domestic and international markets. The company operates in various business segments, including pharmaceutical production, medical device manufacturing, and sale of medical and healthcare products. The pharmaceutical division of CPMC Holdings is one of the largest pharmaceutical manufacturers in China and includes the production and marketing of OTC and prescription drugs, active pharmaceutical ingredients, and other medical products. The company has a comprehensive product portfolio with over 200 drugs in various therapy areas such as gastroenterology, cardiology, oncology, and diabetes. CPMC's products are sold in the Chinese market as well as in other Asian countries. CPMC's medical device division manufactures a variety of medical devices and instruments, including diagnostic and monitoring products, surgical instruments, laboratory equipment, and medical consumables. The company is a major supplier of medical devices to Chinese hospitals and healthcare facilities, and also supplies international markets including Europe, North America, and Japan. In addition to pharmaceuticals and medical devices, CPMC Holdings operates a retail and distribution department that sells medical and healthcare products such as dietary supplements, health products, beauty products, medical care products, and personal protective equipment (PPE) to Chinese consumers. The company has an extensive network of retail stores throughout China as well as an online shop that allows consumers to conveniently order products from home. The unique ability to offer a comprehensive portfolio of pharmaceutical products, medical devices, and healthcare products has allowed CPMC Holdings to establish itself as a key player in the pharmaceutical and medical device manufacturing sector. The company relies on close collaboration with the Chinese government and other health authorities to develop and implement its business and growth strategies. In summary, the business model of CPMC Holdings is a major supplier in the Chinese healthcare market. The company produces and distributes a wide range of pharmaceutical products, medical devices, and healthcare products to meet the health needs of millions of people around the world. With its comprehensive product range and strong network of retail stores and online shops, CPMC is able to meet consumers' demand for healthcare products and continue to be a key player in the healthcare and medical products industry. The answer is: CPMC Holdings Ltd is a leading Chinese provider of pharmaceutical products, medical devices, and healthcare solutions for the domestic and international markets.

CPMC Holdings разпределя дивидента от 0,25 CNY на плащания годишно.

Дивидентата за CPMC Holdings в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на CPMC Holdings е HK0000057171.

WKN на CPMC Holdings е A0YDVU.

Тикерът на CPMC Holdings е 906.HK.

През последните 12 месеца CPMC Holdings изплати дивиденда в размер на 0,24 CNY . Това съответства на дивидендна доходност от около 3,78 %. За следващите 12 месеца се очаква CPMC Holdings да изплати дивиденда в размер на 0,25 CNY.

Дивидентната доходност на CPMC Holdings в момента е 3,78 %.

CPMC Holdings изплаща дивидент на тримесечие. Той се разпределя в месеците юли, октомври, юни, октомври.

CPMC Holdings платеше дивиденда всяка година през последните 16 години.

За идните 12 месеца се очакват дивиденти в размер на 0,25 CNY. Това съответства на дивидентна доходност от 3,99 %.

CPMC Holdings се отнася за сектор 'Суровини'.

За да получите последното дивидентно плащане от CPMC Holdings на 25.09.2023 г. в размер на 0,133 CNY, трябваше да притежавате акцията в портфейла си преди Ex-деня на 4.09.2023 г..

Последното дивидентно плащане беше извършено на 25.09.2023 г..

През година 2023 CPMC Holdings изплати 0,254 CNY под формата на дивиденти.

Дивидентите от CPMC Holdings се изплащат в CNY.